In this article, Deborah Huck-Jones, PhD, product manager, analytical imaging; and Paul Kippax, PhD, micrometrics product group manager & pharmaceutical portfolio manager, both of Malvern Instruments, discuss analytical methods that can be helpful for demonstrating bioequivalence in the development of generic nasal sprays, highlighting the importance of understanding how spray formulations and devices interact to impact drug delivery performance.

Click here for more information.